Elementary school-age children are being given GLP-1 weight loss drugs as a way to prevent lifelong obesity — even though the drugs are not yet approved to treat young patients, according to a report.
Some doctors are prescribing GLP-1s such as Wegovy off-label to children as young as six in the hopes of staving off medical issues that are linked to obesity, such as high blood pressure and Type 2 diabetes, The Wall Street Journal reported.